Heron Therapeutics Inc.

(HRTX) Trade

By |

Profile

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL and CINVANTI. Its pipeline product is HTX-011.

Contact Information

Website: www.herontx.com
Email: ir@herontx.com
Main Phone: +1 858 251-4400
Address: 4242 Campus Point Court
Address 2: Suite 200
State: CA
City / Town: San Diego
Country: US
Postal Code: 92121

Issuer Information

Exchange: NSC
CEO: Barry D. Quart
Employees: 231
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL and CINVANTI. Its pipeline product is HTX-011.

Contact Information

Website: www.herontx.com
Email: ir@herontx.com
Main Phone: +1 858 251-4400
Address: 4242 Campus Point Court
Address 2: Suite 200
State: CA
City / Town: San Diego
Country: US
Postal Code: 92121

Issuer Information

Exchange: NSC
CEO: Barry D. Quart
Employees: 231
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 14.57 $ -0.23 (-1.55%)
Last Price 14.57 Change $ -0.23 Change % -1.55 Tick N/A
Bid 14.00 Bid Size 100.00 Ask 16.48 Ask Size 600.00
Open 14.70 High 14.87 Low 14.27 Prev Close 14.80
Last Trade Volume 691,040 52 Wk Hi 26.81 52 Wk Low 9.61
Market Cap 1.3 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 90,855,254.00 EPS (TTM) -2.25 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 10
Number of Buys 3 6
Number of Sells 2 4
Net Activity 192308 192844
Last 10 Buys Shares
Kevin C. Tang 1,000
John W. Poyhonen 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Barry D. Quart 1,000
Barry D. Quart 1,000
Last 10 Sell Shares
Kimberly J. Manhard 1,000
Barry D. Quart 1,000
Barry D. Quart 1,000
Kimberly J. Manhard 1,000
Kimberly J. Manhard 1,000
Robert H. Rosen 1,000
Robert H. Rosen 1,000
Robert H. Rosen 1,000
Robert H. Rosen 1,000
Robert H. Rosen 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 56 56 56 56
Low Target Price Estimate 30 30 30 30
Mean Target Price Estimate 39.91 39.91 39.91 39.91
Standard Deviation 9.01 9.01 9.01 9.01
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 10 10 10 8
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.09 1.09 1.09 1.11